Patient Affordability and Prescription Drugs

The implications of increasing pharmacy cost exposure on patient behavior and the mitigating role of co-pay card programs in the commercial market

White Paper

August 3, 2018
Patient Affordability and Prescription Drugs
This white paper reviews and expands upon the key insights outlined in our recently published three-part article series on Patient Affordability. As the health care industry grapples with efforts to balance cost and access without unduly burdening patients, strategies must account for increasing complexity within the market. In this white paper, our experts from the IQVIA US Market Access Strategy Consulting team outline the dynamics industry stakeholders must holistically consider to be successful in this effort.